[1]仇秋明,赵英伦.子痫前期患者血清中TFAR19活性研究[J].现代检验医学杂志,2015,30(02):68-69,73.[doi:10.3969/j.issn.1671-7414.2015.02.021]
　QIU Qiu-ming,ZHAO Ying-lun.Serum TFAR19 Activity in Preeclampsia Patients[J].Journal of Modern Laboratory Medicine,2015,30(02):68-69,73.[doi:10.3969/j.issn.1671-7414.2015.02.021]
点击复制

子痫前期患者血清中TFAR19活性研究()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第30卷
期数:
2015年02期
页码:
68-69,73
栏目:
论著
出版日期:
2015-03-20

文章信息/Info

Title:
Serum TFAR19 Activity in Preeclampsia Patients
作者:
仇秋明1; 赵英伦2
1.北京市怀柔区妇幼保健院,北京 101400; 2.广西医科大学第一临床医学院,南宁 530021
Author(s):
QIU Qiu-ming1; ZHAO Ying-lun2
1.Huairou Maternal and Child Health Hospital of Beijing,Beijing 101400,China; 2.the First School of Clinical Medicine Guangxi Medical University,Nanning 530021,Chin
关键词:
子痫前期;  细胞凋亡;  TFAR19
分类号:
R714.245; R392.11
DOI:
10.3969/j.issn.1671-7414.2015.02.021
文献标志码:
A
摘要:
目的观察子痫前期患者血清TFAR19活性。方法 选取北京市怀柔区妇幼保健院住院初产行剖宫产术的子痫前期患者43例,其中重度子痫前期患者18例、轻度子痫前期患者25例,同时随机选取无妊娠并发症的初产剖宫产产妇40例设为对照组,于入院次日采集外周静脉血,采用酶联免疫吸附试验(enzyme-linked immunosorbent assay,ELISA)检测子痫前期患者血清中TFAR19活性,即TFAR19催化产生的吸光度A。结果 重度子痫前期、轻度子痫前期、正常对照组TFAR19活性分别为43.56±2.93,33.38±2.32和23.63±2.94活性单位,各组之间TFAR19活性差异具有统计学意义(F=10.65,P<0.01)。与正常对照组相比,重度子痫前期组(q=6.384,P<0.001)、轻度子痫前期组(q=3.478,P=0.016)TFAR19活性差异均具有统计学意义。重度子痫前期组、轻度子痫前期组之间TFAR19活性差异有统计学意义(q=2.993,P=0.037)。各组之间年龄差异无统计学意义(F=0.091,P=0.913)。各组之间孕周、新生儿体重差异有统计学意义(F=4.37,P=0.016; F=35.06,P=0.00)。结论 TFAR19的增加可促进机体细胞凋亡,参与子痫前期的发生,并且TFAR19的含量可随病情的严重程度而增加。
Abstract:
Objective To explore serum TFAR19 activity in preeclampsia patients.Methods 43 of cesarean delivery patients with preeclampsia in the Huairou Maternal and Child Health Hospital of Beijing were recruited and the peripheral venous blood was collected.Among them,severe preeclampsia patients were 18,mild preeclampsia were patients 25.Inaddition,40 unrelated healthy cesarean puerpera from a routine health survey were enrolled as controls.Enzyme-linked immunosorbent assay(ELISA)was used to detect serum TFAR19 activity in preeclampsia patients.That was absorbancy-Acatalytic generated by TFAR19.Results The activity of TFAR19 severe preeclampsia patients,mild preeclampsia patients,and healthy controls were 43.56±2.93,33.38±2.32 and 23.63±2.94,respectively.The TFAR19 activity in each group was statistically significant difference(F=10.65,P<0.01).Compared with healthy controls,the TFAR19 activity in severe preeclampsia group(q=6.384,P<0.001),mild preeclampsia group(q=3.478,P=0.016)was statistically significant difference.The TFAR19 activity in preeclampsia patients subgroups(severe preeclampsia group,mild preeclampsia group)was statistically significant difference(q=2.993,P=0.037).Age between each groups was no-statistically significant difference(F=0.091,P=0.913).Gestation age and neonatal weight betweeneach groups was statistically significant difference(F=4.37,P=0.016; F=35.06,P<0.001).ConclusionThe increase of TFAR19 could promote apoptosis,participating the occurrence of preeclampsia.The content of TFAR19 could be increased with the severity of the preeclampsia.

参考文献/References:

[l] 田辉凯,夏 天,蒋春笋,等.TFARl9促进小鼠肝线粒体膜通透性转运孔的开放[J].生物化学与生物物理学报,2002,34(3):279-284. Tian HK, Xia T, Jiang CS,et al.TFAR19 enhances the opening of permeability transition porin the mitochondrial membrane of mice liver[J].Acta Biochlmlca et Biophysica Sinica,2002,34(3):279-284.
[2] Wang Y,Li X,Wang L,et al.An alternative form of paraptosis-like celldeath,triggered by TAJ/TROY,and enhanced by PDCD5 overexpression[J].J Cell Sci,2004,117(Pt8):1525-1532.
[3] Guo HR,Lu SQ.The study of pathogenesis in preeclamptic pregnancies[J].Chin J Misdiagn,2008,84(2):776-778.
[4] Coelho TM,Sass N,Camano L.Microvessel density in the placental bed among preeclampsia patients[J].Sao Paulo Med J,2006,124(2):96-100.
[5] Rodrigues RF,Carter AM,Ambrosio CE,et al.The su-bplacenta of tbe red-ramped agouti(Dasyprocta leporina L)[J].Reprod Bid Endoerinol,2006,4(1):31.
[6] Huppenz B,Kadyrov M,Kingdom JC.Apoplosis and its role in the tmphoblast[J].Am J Obstet Gynecol,2006,195(1):29-39.
[7] Levy R,Smith SD,Yusuf K,et al.Trophoblast apoptosis from pregnanciescomplicated by fetal growth restriction is associated with enhanced p53 expression[J].Am J Obstet Gynecol,2002,186(5):1056-1061.
[8] Reister F,Frank HG,Kingdom JG,et al.Macrophage induced apoptosis limits endovascular trophoblast invasion in tlle uterine wall of preeclampsia women[J].Lab Invest,2002,81(8):1143-1152.
[9] Crocker IP,Cooper S,Ong SC,et al.Difference in ap-optotic susceptibility of cytotrophoblasts and syncytiotrophoblasts in normal pregnancy to those complicated with preeclampsia and intrauterine growth restriction[J].Am J Pathol,2003,162(2):637-643.

相似文献/References:

[1]白 茹,仇秋明.凋亡促进分子TFAR19与子宫肌瘤关系的研究[J].现代检验医学杂志,2016,31(05):94.[doi:10.3969/j.issn.1671-7414.2016.05.025]
　BAI Ru,QIU Qiu-ming.Relationship between Apoptosis Promoting Effector Molecule TFAR19 and Uterine Myoma[J].Journal of Modern Laboratory Medicine,2016,31(02):94.[doi:10.3969/j.issn.1671-7414.2016.05.025]
[2]郭进京.孕中期母血PAPPA与PIGF在预测子痫前期发生的作用[J].现代检验医学杂志,2016,31(05):115.[doi:10.3969/j.issn.1671-7414.2016.05.032]
　GUO Jin-jing.Role of Maternal PAPPA and PIGF Levels at Second Trimester in the Prediction of Preeclampsia[J].Journal of Modern Laboratory Medicine,2016,31(02):115.[doi:10.3969/j.issn.1671-7414.2016.05.032]
[3]袁长巍,曹兴午.精液脱落细胞检测在无精子症中的应用价值[J].现代检验医学杂志,2016,31(06):1.[doi:10.3969/j.issn.1671-7414.2016.06.001]
　YUAN Chang-wei,CAO Xing-wu.Application Value of Detection of Sperm Cells Exfoliated in the Absence of Sperm[J].Journal of Modern Laboratory Medicine,2016,31(02):1.[doi:10.3969/j.issn.1671-7414.2016.06.001]
[4]王秀珍,李连友,王秀梅.子痫前期患者血清中PDGF-BB和U-Ⅱ检测的临床价值[J].现代检验医学杂志,2016,31(06):82.[doi:10.3969/j.issn.1671-7414.2016.06.023]
　WANG Xiu-zhen,LI Lian-you,WANG Xiu-mei.Clinical Value of Serum PDGF-BB and U-Ⅱ in Patients with Preeclampsia[J].Journal of Modern Laboratory Medicine,2016,31(02):82.[doi:10.3969/j.issn.1671-7414.2016.06.023]
[5]和新盈,王书文,李 宇,等.miR-25靶向作用FBXO33在肾透明细胞癌凋亡及预后的相关实验研究[J].现代检验医学杂志,2017,32(01):38.[doi:10.3969/j.issn.1671-7414.2017.01.011]
　HE Xin-ying,WANG Shu-wen,LI Yu,et al.Study on the Relationship of MiR-25 Targeting FBXO33 with Cell Apoptosis and Prognosis in Renal Cell Carcinoma[J].Journal of Modern Laboratory Medicine,2017,32(02):38.[doi:10.3969/j.issn.1671-7414.2017.01.011]
[6]赵英伦,马 元,李东冉,等.凋亡促进因子TFAR19,Apaf-1与腰椎间盘突出症的关系研究[J].现代检验医学杂志,2017,32(02):30.[doi:10.3969/j.issn.1671-7414.2017.02.008]
　ZHAO Ying-lun,MA Yuan,LI Dong-ran,et al.Relationship between Apoptosis Promoting Effector Molecules TFAR19, Apaf-1 and Lubar Intervertebral Disc Protrusion[J].Journal of Modern Laboratory Medicine,2017,32(02):30.[doi:10.3969/j.issn.1671-7414.2017.02.008]
[7]甘 露a,刘西玲b,王 婷c,等.子痫前期患者血清及尿液中miR-125a/b-5p的表达及相关临床研究[J].现代检验医学杂志,2017,32(06):32.[doi:10.3969/j.issn.1671-7414.2017.06.001]
　GAN Lua,LIU Xi-lingb,WANG Tingc,et al.Expression of miR-125a/b-5p in Serum and Urine of Preeclampsia and Related Clinical Studies[J].Journal of Modern Laboratory Medicine,2017,32(02):32.[doi:10.3969/j.issn.1671-7414.2017.06.001]
[8]吕艳关,王丽,赵玉杰.子痫前期患者血清PCT,HSP9及hs-CRP检测的临床意义[J].现代检验医学杂志,2018,33(04):83.[doi:10.3969/j.issn.1671-7414.2018.04.022]
　LV Yan-guan,WANG Li,ZHAO Yu-jie.Clinical Significance of Detecting Serum PTC,HSP90 and hs-CRP in Patients with Pre-Eclamptic L[J].Journal of Modern Laboratory Medicine,2018,33(02):83.[doi:10.3969/j.issn.1671-7414.2018.04.022]
[9]赵英伦,马 元,莫 森,等.腰椎间盘突出症患者血清中Caspase-3和Caspase-9活性研究[J].现代检验医学杂志,2018,33(02):13.[doi:10.3969/j.issn.1671-7414.2018.02.001]
　ZHAO Ying-Lun,MA Yuan,MO Sen,et al.Serum Caspase-3 and Caspase-9 Activity in Patients with Lubar Intervertebral Disc Protrusion[J].Journal of Modern Laboratory Medicine,2018,33(02):13.[doi:10.3969/j.issn.1671-7414.2018.02.001]
[10]崔普芳,刘爱胜,李　喆,等.深圳龙华区孕妇血清维生素Ｄ水平及其受体基因rs2228570多态性与子痫前期易感性相关性研究[J].现代检验医学杂志,2021,36(05):23.[doi:10.3969/j.issn.1671-7414.2021.05.005]
　CUI Pu-fanga,LIU Ai-shengb,LI Zhea,et al.Study on the Correlation between Serum Vitamin D Level and rs2228570Polymorphism of Its Receptor Gene and Preeclampsia Susceptibility inPregnant Women in Shenzhen Longhua District[J].Journal of Modern Laboratory Medicine,2021,36(02):23.[doi:10.3969/j.issn.1671-7414.2021.05.005]

备注/Memo

备注/Memo:
作者简介:仇秋明(1976-),女,主治医师,研究方向:产科,Tel:18610129915,E-mail:869405756@qq.com。
更新日期/Last Update: 2015-03-20